bioAffinity Technologies, Inc. (BIAF) Q1 2024 Annual Earnings
BIAF·Reported May 15, 2024·Before market open
bioAffinity Technologies, Inc. reported Q1 2024 revenue of $2.4M, missed analyst consensus of $2.5M by $134.0K. Diluted EPS came in at $-0.21, missed the $-0.15 consensus by $0.06.
Revenue
$2.4Mmissed by $134.0K
Consensus: $2.5MDiluted EPS
$-0.21missed by $0.06
Consensus: $-0.15
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about bioAffinity Technologies, Inc.'s Q1 2024 earnings report.
bioAffinity Technologies, Inc. (BIAF) reported Q1 2024 earnings on May 15, 2024 before market open.
bioAffinity Technologies, Inc. reported revenue of $2.4M and diluted EPS of $-0.21 for Q1 2024.
Revenue missed the consensus estimate of $2.5M by $134.0K. EPS missed the consensus estimate of $-0.15 by $0.06.
You can read the 10-K periodic report (0001493152-24-012358) directly on SEC EDGAR. The filing index links above go to sec.gov.